Allgens Medical Technology CO., LTD. (SHA:688613)
23.11
+0.82 (3.68%)
Mar 10, 2026, 1:24 PM CST
SHA:688613 Market Cap
SHA:688613 has a market cap or net worth of 3.05 billion as of March 9, 2026. Its market cap has increased by 28.96% in one year.
Market Cap
3.05B
Enterprise Value
2.06B
Revenue
223.51M
Ranking
n/a
PE Ratio
222.90
Stock Price
23.11
Market Cap Chart
Since May 21, 2021, SHA:688613's market cap has decreased from 12.67B to 3.05B, a decrease of -75.89%. That is a compound annual growth rate of -25.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.05B | 9.75% |
| Dec 31, 2025 | 2.78B | 13.79% |
| Dec 31, 2024 | 2.45B | -17.61% |
| Dec 29, 2023 | 2.97B | -4.95% |
| Dec 30, 2022 | 3.12B | -57.62% |
| Dec 31, 2021 | 7.37B | -41.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangdong Transtek Medical Electronics | 3.07B |
| Zhejiang Tailin BioEngineering Co.,Ltd | 3.05B |
| Kontour (Xi'an) Medical Technology | 3.16B |
| Shanghai Kehua Bio-Engineering Co.,Ltd | 2.99B |
| Shanghai General Healthy Information and Technology | 2.92B |
| Beijing Succeeder Technology | 3.37B |
| Tellgen | 2.83B |
| Guangdong Biolight Meditech | 3.39B |